top of page

Numair Arshad

Content writer – Clinical

Numair is a Clinical content writer at Rhenix. He is responsible for writing scientific medical whitepapers and blogs. His work is centered around making complex scientific concepts accessible to lay people. He is currently pursuing PharmD at Lahore University.

His writing at Rhenix focuses on precision medicine for cancer patients. Numair is currently working on gene map projects and delivering scientific content that aims to provide gene-centric information for various diseases and their treatments.

Rhenix has allowed him to gain leadership in various projects related to content.

Stories

Summary "Slowing down glioma growth by knocking out miR-21 in mice models."

Glioblastoma multiforme (GBM) is an aggressive form of glioma with a median survival of 15 months. Heterogeneity is one of the main characteristics of GBM. The tumor cells show variability not only from one...

Glioblastoma Multiforme - NA.jpg

Summary "Slowing down Alzheimer’s disease by combining an anti-oxidant drug, GV1001, with donepezil."

Alzheimer’s disease (AD) is a neurogenerative disease that impairs short-term memory and affects the judgment and behavior of the patient. Brain cells continue to die as time passes and the patient...

Alzheimer's disease.jpg

Summary "Exploring the safety and efficacy of a novel drug combination for treating recurrent high-grade astrocytomas: A phase 1 clinical trial."

Astrocytoma is a type of brain tumor that originates from star-shaped glial cells in the brain called astrocytes. According to the WHO classification, they are classified into four grades based on the degree of malignancy and...

Astrocytoma.jpg

Summary "My experience with ChatGPT."

As a PharmD student working part-time in Rhenix Lifesciences, content creation is a big part of my job. I spend my days learning about the mechanism of action of drugs and writing white papers, blogs, and short...

ChatGPT.jpg

Summary "Observation vs. radiosurgery: Which is best for asymptomatic meningiomas."

Meningiomas are the most common intracranial tumors, accounting for almost 30% of all central nervous system (CNS) tumors in adults. A great majority of meningiomas are benign, correlating to grade I...

Asymptomatic Meningiomas.jpg

Summary "Clinical trial shows potential of poziotinib for HER2-mutant lung cancer."

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for up to 85% of the patients. Around 3% of these NSCLC patients have mutations in the human epidermal growth factor receptor 2...

Non-Small-Cell Lung Cancer

Videos

Slowing down glioma growth by knocking out miR-21 in mice models | CellTalk

Glioblastoma multiforme (GBM) is an aggressive form of glioma with a median survival of 15 months. Heterogeneity is one of the main characteristics of GBM. The tumor cells show variability not only from one...

Slowing down Alzheimer’s disease by combining an anti-oxidant drug, GV1001, with donepezil | CellTalk

Alzheimer’s disease (AD) is a neurogenerative disease that impairs short-term memory and affects the judgment and behavior of the patient. Brain cells continue to die as time passes and the patient eventually becomes...

Exploring the safety and efficacy of a novel drug combination for treating recurrent high-grade astrocytomas: A phase 1 clinical trial | CellTalk

Astrocytoma is a type of brain tumor that originates from star-shaped glial cells in the brain called astrocytes. According to the WHO classification, they are classified into four grades based on the degree of malignancy and...

My experience with ChatGPT | CellTalk

I spend my days learning about the mechanism of action of drugs and writing white papers, blogs, and short descriptions about diseases, as well as creating graphics that explain complex scientific concepts to a non-expert...

Observation vs. radiosurgery: Which is best for asymptomatic meningiomas | CellTalk

Meningiomas are the most common intracranial tumors, accounting for almost 30% of all central nervous system (CNS) tumors in adults. A great majority of meningiomas are benign, correlating to grade I of World Health Organization (WHO)...

Clinical trial shows potential of poziotinib for HER2-mutant lung cancer | CellTalk

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for up to 85% of the patients. Around 3% of these NSCLC patients have mutations in the human epidermal growth factor receptor 2...

Connecting Dots

Get the latest updates

Join Celltalk!

Subscribe us today & receive latest updates on your mail !

bottom of page